Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 85.20

From 52W high−33.76%

Volume2.80M

Market capCNY 14.28B

P/E (TTM)−65.5x

P/S (TTM)34.9x

Div yield—

Key dataSep 18, 2026

Open

CNY 85.20

From 52W high

−33.76%

Volume

2.80M

Market cap

CNY 14.28B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−114.6x

P/E (TTM)

−65.5x

RSI (14)

41.0

MomentumView details →

1D Return

−3.72%

YTD Return

−2.91%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

−65.5x

EV/EBITDA

−114.6x

EV/Sales

35.5x

P/S (TTM)

34.9x

P/B (TTM)

56.8x

ProfitabilityView details →

Gross Margin

62.64%

Net Margin

−51.60%

EBITDA Margin

−31.00%

ROE (TTM)

−85.57%

ROA (TTM)

−15.23%

Asset Turnover

0.30x

GrowthView details →

Revenue YoY

−0.43%

EPS YoY

−26.52%

FCF YoY

—

Revenue CAGR 3Y

+2.58%

EPS CAGR 3Y

−39.37%

EBITDA YoY

—

MomentumView details →

1D Return

−3.72%

YTD Return

−2.91%

1Y Return

−19.84%

RSI (14)

41.0

vs 50D SMA

−6.23%

vs 200D SMA

−14.39%

Capital & dividendView details →

Debt/Equity

1.67x

Current Ratio

1.02x

Quick Ratio

0.77x

Div Yield

—

Div Rate

—

Div Growth 1Y

−60.00%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

417.21M

Net Income (TTM)

−215.28M

Op. CF (TTM)

−42.59M

Latest newsMore news →

Guangshengtang plans to acquire all technology and rights to Ruitailai's desvenlafaxine succinate sustained-release tablets for 12.636 million yuan.9d ago

Similar companies

晶瑞电材300655.SZ 海川智能300720.SZ 华宏科技002645.SZ 乔锋智能301603.SZ 安科生物300009.SZ 力量钻石301071.SZ Find similar companies →

Latest newsMore news →

Guangshengtang plans to acquire all technology and rights to Ruitailai's desvenlafaxine succinate sustained-release tablets for 12.636 million yuan.9d ago